Overview

Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP)

Status:
NOT_YET_RECRUITING
Trial end date:
2026-11-01
Target enrollment:
Participant gender:
Summary
The goal of this cluster randomized controlled trial is to determine the optimal treatment for community aquired pneumonia (CAP). The study compares the effects and side effects of hydrocortisone and prednisolone in patients above 18 years old diagnosed with severe CAP. The main question is whether there is a difference in all cause mortality within thirty days. Participants will be randomized to receive treatment with either hydrocortisone or prednisolone.
Phase:
PHASE4
Details
Lead Sponsor:
Copenhagen Respiratory Research
Treatments:
Hydrocortisone
Methylprednisolone
Pharmaceutical Preparations